ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 127 filers reported holding ACLARIS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $43,000 | – | 2,383 | +201.3% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 791 | -35.0% | 0.00% | – |
| Q4 2019 | $2,000 | -60.0% | 1,216 | -73.5% | 0.00% | – |
| Q3 2019 | $5,000 | +400.0% | 4,595 | +609.1% | 0.00% | – |
| Q2 2019 | $1,000 | -90.0% | 648 | -61.0% | 0.00% | -100.0% |
| Q1 2019 | $10,000 | +11.1% | 1,663 | +40.9% | 0.00% | 0.0% |
| Q4 2018 | $9,000 | +350.0% | 1,180 | +1538.9% | 0.00% | – |
| Q1 2017 | $2,000 | – | 72 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 1,258,243 | $8,618,965 | 13.75% |
| Foresite Capital Management IV, LLC | 2,808,034 | $19,235,033 | 10.68% |
| Bain Capital Life Sciences Investors, LLC | 3,400,000 | $23,290,000 | 2.60% |
| GREAT POINT PARTNERS LLC | 1,691,768 | $11,588,611 | 2.11% |
| Samsara BioCapital, LLC | 696,171 | $4,768,771 | 1.46% |
| Altium Capital Management LP | 403,000 | $2,760,550 | 1.44% |
| BVF INC/IL | 7,064,736 | $48,393,442 | 1.30% |
| Aisling Capital Management LP | 434,455 | $2,976,017 | 1.23% |
| GREAT POINT PARTNERS LLC | 700,000 | $4,795,000 | 0.87% |
| VR Adviser, LLC | 1,040,754 | $7,129,165 | 0.75% |